602
Helvetica Chimica Acta – Vol. 98 (2015)
25,26,27,28-Tetrakis[(3,5-bis{[4-(tert-butoxycarbonyl)benzyl]oxy}benzyl)oxy]calix[4]arene (19).
Eluent: hexane/AcOEt (10 :1). Yield: 62%. Colorless solid. M.p. 99 – 1028. 1H-NMR (250 MHz, CDCl3):
1.57 (s, 8 Me3C); 2.86 (d, 2J ¼ 13.50, 2 ArCH2Ar); 4.17 (d, 2J ¼ 13.50, 2 ArCH2Ar); 4.78 (s, 8 ArO-
4
CH2Ar’); 5.06 (s, 4 Ar’OCH2Ar’’); 6.43 (t, J ¼ 2.00, 4 arom. H (Ar’)); 6.55 – 6.58 (m, 20 arom. H (Ar’,
3
3
Ar’’)); 7.22 (d, J ¼ 8.25, 16 arom. H (Ar’’)); 7.87 (d, J ¼ 8.25, 16 arom. H (Ar’’)). 13C-NMR (63 MHz,
CDCl3): 28.49; 31.71; 69.39; 76.08; 81.12; 101.81; 108.64; 122.47; 127.08; 128.32; 129.87,131.56; 135.29;
140.32; 141.49; 155.28; 159.51; 165.52. HR-ESI-MS (matrix: CsCO3): 2567.0969 ([M þ Cs]þ,
C152H162CsOþ28
;
calc. 2568.0307). MALDI-TOF-MS (matrix: DCTB): 2459.611 ([M þ Na]þ,
C152H162CsOþ28 ; calc. 2458.1150). Anal. calc. for C152H162O28 (2436.90): C 74.92, H 6.70; found: C74.61,
H 6.62.
25,26,27,28-Tetrakis{[3,5-bis({3,5-bis[(4-bromobenzyl)oxy]benzyl}oxy)benzyl]oxy}calix[4]arene
(20). Eluent: hexane/CH2Cl2 (4 :1). Yield: 25%. Colorless solid. M.p. 77 – 798. 1H-NMR (250 MHz,
CDCl3): 2.91 (d, 2J ¼ 13.50, 2 ArCH2Ar); 4.21 (d, 2J ¼ 13.50, 2 ArCH2Ar); 4.61 (s, 8 Ar’OCH2Ar’’); 4.71
(s, 16 Ar’’OCH2Ar’’’); 5.05 (s, 4 ArOCH2Ar’’); 6.35 – 6.59 (m, 48 arom. H (Ar’, Ar’’)); 7.11 (d, 3J ¼ 8.25, 32
arom. H (Ar’’’)); 7.39 (d, 3J ¼ 8.25, 32 arom. H (Ar’’’)). 13C-NMR (63 MHz, CDCl3): 31.87; 69.37; 69.98;
101.61; 102.02; 106.64; 108.57; 122.17; 122.81; 128.47; 129.34; 131.91; 135.22; 135.87; 139.59; 140.54;
155.69; 159.64; 160.01. MALDI-TOF-MS (matrix: DCTB): 4620.687 ([M þ Na]þ, C224H178Br16NaO2þ8
;
calc. 4619.2471). Anal. calc. for C224H178Br16O28 (4596.26): C 58.53, H 3.90; found: C 58.61, H 3.77.
25,26,27,28-Tetrakis({3,5-bis[(3,5-bis{[(4-tert-butoxycarbonyl)benzyl]oxy}benzyl)oxy]benzyl}oxy)-
calix[4]arene (21). Eluent: hexane/acetone/AcOEt (12 :2 :1). Yield: 30%. Colorless solid. M.p. 107 –
1108. 1H-NMR (250 MHz, CDCl3): 1.55 (s, 16 Me3C); 2.87 (d, 2J ¼ 14.00, 2 ArCH2Ar); 4.21 (d, 2J ¼
14.00, 2 ArCH2Ar); 4.64 (s, 8 Ar’OCH2Ar’’); 4.80 (s, 16 Ar’’OCH2Ar’’’); 5.06 (s, 4 ArOCH2Ar’’); 6.35 –
3
3
6.59 (m, 48 arom. H (Ar’, Ar’’)); 7.29 (d, J ¼ 8.25, 32 arom. H (Ar’’’)); 7.89 (d, J ¼ 8.25, 32 arom. H
(Ar’’’)). 13C-NMR (63 MHz, CDCl3): 28.49; 31.81; 69.20; 69.90; 81.05; 101.59; 102.10; 106.37; 108.39;
122.47; 127.14; 128.45; 129.89; 131.64; 135.26; 139.51; 140.45; 141.32; 155.34; 159.66; 159.94; 165.55. HR-
ESI-MS (matrix: DHB): 4956.0000 ([M þ Na]þ, C304H322NaO6þ0 ; calc. 4955.2043). Anal. calc. for
C304H322O60 (4935.77): C 73.98, H 6.58; found C 73.84, H 6.65.
26,28-Bis{[3,5-bis({3,5-bis[(3,5-bis{[4-(tert-butoxycarbonyl)benzyl]oxy}benzyl)oxy]benzyl}oxy)-
benzyl]oxy}-25,27-dihydroxycalix[4]arene (22). Eluent: hexane/AcOEt (4 :1). Yield: 7%. Colorless
solid. 1H-NMR (250 MHz, CDCl3): 1.55 (s, 16 Me3C); 3.30 (d, 2J ¼ 13.00, 2 ArCH2Ar); 4.30 (d, 2J ¼ 13.00,
2 ArCH2Ar); 4.69 (s, 4 Ar’OCH2Ar’’); 4.77 (s, 8 Ar’’OCH2Ar’’’); 4.90 (s, 16 Ar’’’OCH2Ar’’’’); 5.06 (s,
ArOCH2Ar’); 6.38 – 7.00 (m, 54 arom. H (Ar’, Ar’’, Ar’’’)); 7.34 (d, 3J ¼ 8.00, 32 arom. H (Ar’’’)); 7.92 (d,
3J ¼ 8.00, 32 arom. H (Ar’’’)); 7.99 (s, 2 ArOH). 13C-NMR (63 MHz, CDCl3): 28.25; 31.69; 69.36; 69.88;
81.19; 101.52; 101.72; 105.63; 106.33; 106.61; 126.84; 128.14; 128.68; 129.68; 131.66; 133.37; 139.40;
139.60; 139.90; 141.35; 152.17; 153.45; 159.95; 160.32; 165.59. MALDI-TOF-MS (matrix: DCTB):
5197.5120 ([M þ Na]þ, C318H332NaOþ64 ; calc. 5197.2622). Anal. calc. for C318H332O64 (5178.00): C 73.76, H
6.46; found C 73.45, H 6.39.
REFERENCES
[1] E. Buhleier, W. Wehner, F. Vçgtle, Synthesis 1978, 155.
[2] F. Vçgtle, G. Richardt, N. Werner, ꢀDendrimer Chemistry: Concepts, Syntheses, Properties,
Applicationsꢁ, Wiley – VCH, Weinheim, 2009; Z. Aguilar, ꢀNanomaterials for Medical Applicationsꢁ,
Elsevier, 2012; R. M. Pearson, S. Sunogrot, H. J. Hsu, J. W. Bae, S. Hong, Ther. Deliv. 2012, 3, 94; Y.
Liu, N. Zhang, Biomaterials 2012, 33, 5363; A. M. Caminade, A. Ouali, M. Keller, J. P. Majoral,
Chem. Soc. Rev. 2012, 7, 4113; D. Astruc, Nat. Chem. 2012, 22, 255; M. A. Quadir, R. Haag,
J. Control Release 2012, 161, 484; J. Khandare, M. Calderón, N. M. Dagia, R. Haag, Chem. Soc. Rev.
2012, 7, 2824; L. M. Bronstein, Z. B. Shifrina, Chem. Rev. 2011, 111, 5301; V. Percec, M. R. Imam, M.
Peterca, P. Leowanawat, J. Am. Chem. Soc. 2012, 134, 4408; X. Cai, J. Hu, J. Xiao, Y. Cheng, Expert
Opin. Ther. Pat. 2013, 23, 4, 515; B. Klajnert, M. Rozanek, M. Bryszewska, Curr. Med. Chem. 2012,
19, 4903.
[3] C. J. Hawker, J. M. J. FrØchet, J. Am. Chem. Soc. 1990, 112, 7638.